dissolvable glp 1 THRIVE myGLP GLP-1 Activation Technology Strips and more with this must Patients Are Left With Few

Schmitt C, Portron A, Jadidi S, Sarkar N, DiMarchi R

Novo will get access to Aspects bioprinting technology and plans to use this 3D-tissue printing tech to develop up to four products for T2D and obesity

(Source: The RX Index, May 2026) Clinical Support Measurably Reduces Discontinuation Evidence presented at the American Diabetes Association 2026 Scientific Sessions showed that involving registered dietitian nutritionists reduces GLP-1 discontinuation rates by 5 to 10% in trials and likely more in real-world practice

Sobo approaches weight loss as long-term metabolic care

In patients with type-2 diabetes, glucagon AUC was significantly reduced on days one and three when compared to day two (1096 109 (day 1) and 1116 108 (day 3) 3h pmol/liter vs